|
|
Celebrex Class Action Lawsuits Information
Celebrex arthritis drug entered the U.S. marketed in January
1999 with record sales within the first 15 weeks. It did not take long for
people to begin to question the "super aspirin" as reports linking Celebrex to
death and serious side effects began to come in just three months on the market.
Individuals looking for pain relief due to arthritis were suffering death,
gastrointestinal hemorrhages, cardiovascular problems, kidney and liver damages,
and ulcers.
The FDA began to send Celebrex manufacture, Pharmacia, warnings that the agency
was concerned with the promotional advertisements that were misrepresenting the
safety of Celebrex. The lack of changes implemented by the Celebrex manufacturer
led to the FDA finally issuing a letter to the drug company on April 6, 2000.
The agency was not satisfied with the company's representation of the safety
information, the unsubstantiated comparative claims, the lack of fair balance,
and the misrepresentation of efficacy information, stating, "your
representatives continue to engage in violative promotional practices".
In one year, Celebrex brought in $2.2 billion attributed to the company's
aggressive marketing campaigns. Celebrex advertisements claimed that the
arthritis medication was safer and gentler on the stomach compared to older
NSAIDS. A study performed on Celebrex, called the CLASS study, concluded a
"clinically meaningful" safety advantage of Celebrex over older NSAIDS had not
in fact been established.
The CLASS study also failed to show that Celebrex worked any more safely than
NSAIDS regarding ulcer complications. Celebrex manufacturer then began to make
television ads without naming Celebrex to avoid Federal laws requiring side
effects to be stated on the advertisements. Both Celebrex maker and rival Vioxx
made continuous attempts to have label warnings removed in order to gain the
upper hand on one another.
The tight competition between the two arthritis drugs was highly criticized for
sacrificing patient safety. Most recently, Pharmacia experienced large profit
loss after physicians and insurers have grown tired of the pricey medication
that has not yet proven to be more effective than a standard painkiller.
Celebrex Side Effects
Celebrex side effects are serious and life threatening, with
reports of death, cardiovascular problems, kidney and liver damages, and ulcers.
The Celebrex side effects experienced were the source of criticism by many
people that felt the company did its best to minimize the appearance of Celebrex
side effects in order to gain an upper hand with competing arthritis drug Vioxx.
Within months of its entrance to the U.S. market, Celebrex side effects were
reported, accounting for 10 deaths and 11 instances of gastrointestinal
hemorrhages.
The pharmaceutical company pushed for the removal of certain Celebrex side
effects warning labels to be removed in order to gain marketing advantages.
Celebrex patients immediately responded to Celebrex advertisements that showed
the great benefits of the arthritis drug but did not seem to adequately warn of
Celebrex side effects. The FDA sent Celebrex maker a letter due to the
misrepresentation the agency felt the company was making about Celebrex in its
attempts to deter attention away from Celebrex side effects.
More Celebrex Information
The information on Celebrex that Celebrex maker was supplying
seemed to greatly emphasize minor benefits while the serious Celebrex side
effects were not properly supplied to patients. When information on Celebrex was
reported to have deadly and serious events patients felt the heated marketing
battle Celebrex maker was in with a rival arthritis drug caused for the lack of
warnings. A top selling arthritis drug, Celebrex raised serious concerns about
the push for financial benefits by large pharmaceutical companies and the
seemingly diminished focus on patient safety.
Information on Celebrex labeling was requested by Celebrex maker to be changed
to have certain warning information on Celebrex removed in attempts to better
distinguish the arthritis drug from other top competitors. The FDA was not
pleased with the marketing strategies the Celebrex company used and sent a
letter stating the agency was unhappy with the way information on Celebrex was
being supplied. According to adverse reaction information on Celebrex, patients
have suffered death, cardiovascular problems, kidney and liver damage, and
ulcers.
For more free legal information on known dangerous drugs and Class Action Lawsuits, please use the
links below:
|
